Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1
- 저널
- JOURNAL OF ETHNOPHARMACOLOGY137(3) · pp.1207 · 2011
- 피인용
- Web of Science 44
- JCR IF
- JCR 2010 2.466
- ISSN
- 0378-8741
저자
- 장지연제1저자Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
- 김하늬Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
- 김유리Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
- 최우영Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
- Choi, Yung HyunDepartment of Biochemistry, College of Oriental Medicine, Dongeui University, South Korea
- 신화경Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
- 최병태교신저자Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, South Korea
초록
Ethnopharmacological relevance: Nardostachys chinensis has been used in folk medicine to treat melasma and lentigines in Korea. We investigated the inhibitory activities of Nardostachys chinensis in melanogenesis and its related signaling pathway. Materials and methods: Bioassay-guided fractionation of Nardostachys chinensis using solvent partitioning and purification with octadecylsilane open-column chromatography resulted in partial purification. The active 20% methanol chromatographic fraction from the ethyl acetate layer (PPNC) was used to investigate melanogenesis by melanin synthesis, tyrosinase activity assay, cAMP assay, Western blot and flow cytometric analyses in B16F10 mouse melanoma cells. Results: PPNC markedly inhibits melanin synthesis and tyrosinase activity in a concentration-dependent manner. We also found that PPNC decreases microphthalmia-associated transcription factor (MITE), tyrosinase, tyrosinase-related protein (TRP)-1, and dopachrome tautomerase (Dct) protein expressions and MITE and tyrosinase mRNA levels. Moreover, PPNC reduces intracellular CAMP levels and activates mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI3K)/Akt expression in B16F10 cells. The specific MEK/ERK inhibitor PD98059 and PI3K/Akt inhibitor LY294002, block the PPNC-induced hypopigmentation effect, and abrogate the PPNC-suppressed expression of melanogenic proteins such as MITE, tyrosinase, TRP-1, and Dct. Using flow cytometry, we elucidated whether PPNC directly induces ERK phosphorylation at the level of an intact single cell. PPNC shows marked expression of phosphorylated ERK in live B16F10 cells and abrogates PPNC-induced phosphorylated ERK by PD98059 treatment. Conclusions: PPNC stimulates MEK/ERK phosphorylation and PI3K/Akt signaling with suppressing cAMP levels and subsequently stimulating MITE and TRPs down-regulation, resulting in melanin synthesis suppression. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
키워드
Nardostachys chinensiscAMPMicrophthalmia-associated transcription factorExtracellular signal-related kinasePhosphatidylinositol 3-kinaseINDIAN MEDICINAL-PLANTSCYCLIC-AMPSKIN PIGMENTATIONNEURITE OUTGROWTHPC12D CELLSMELANOGENESISJATAMANSIMICROPHTHALMIAINHIBITIONEXTRACT
식별자
- WoS UID
- 000297387000022



로그인
연구물 목록으로